Search research articles
Contact Us
Filters
Showing results (71-80 of 123) with videos related to
Page
of 13
Sort By:
The Journal of Biological Chemistry
|
November 18, 2008
Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets
Xiao-Yan Du, Brian A Zabel, Timothy Myles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2002
A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer
Alfred E Chang, Bruce G Redman, Joel R Whitfield, et al.
Chemistry & Biology
|
June 24, 2006
Rational design of combination enzyme therapy for celiac sprue
Matthew Siegel, Michael T Bethune, Jonathan Gass, et al.
NPJ Precision Oncology
|
March 30, 2024
Tumor heterogeneity and clinically invisible micrometastases in metastatic breast cancer-a call for enhanced surveillance strategies
Eliza R Bacon, Kena Ihle, Weihua Guo, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients' blood
Brian Orcutt-Jahns, Joao Rodrigues Lima Junior, Russell C Rockne, et al.
Ebiomedicine
|
January 26, 2020
Breast cancer induces systemic immune changes on cytokine signaling in peripheral blood monocytes and lymphocytes
Lei Wang, Diana L Simons, Xuyang Lu, et al.
International Journal of Cancer
|
November 9, 2012
Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients
Neta S Zuckerman, Hongxiang Yu, Diana L Simons, et al.
Nature Immunology
|
July 10, 2019
Connecting blood and intratumoral T<sub>reg</sub> cell activity in predicting future relapse in breast cancer
Lei Wang, Diana L Simons, Xuyang Lu, et al.
NPJ Systems Biology and Applications
|
October 10, 2024
Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients' blood
Brian Orcutt-Jahns, Joao Rodrigues Lima Junior, Emily Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2003
A phase I trial of SD-9427 (progenipoietin) with a multipeptide vaccine for resected metastatic melanoma
Vinod Pullarkat, Peter P Lee, Ronaldo Scotland, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 123) with videos related to
Sort By:
Page
of 13
The Journal of Biological Chemistry
|
November 18, 2008
Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets
Xiao-Yan Du, Brian A Zabel, Timothy Myles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2002
A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer
Alfred E Chang, Bruce G Redman, Joel R Whitfield, et al.
Chemistry & Biology
|
June 24, 2006
Rational design of combination enzyme therapy for celiac sprue
Matthew Siegel, Michael T Bethune, Jonathan Gass, et al.
NPJ Precision Oncology
|
March 30, 2024
Tumor heterogeneity and clinically invisible micrometastases in metastatic breast cancer-a call for enhanced surveillance strategies
Eliza R Bacon, Kena Ihle, Weihua Guo, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients' blood
Brian Orcutt-Jahns, Joao Rodrigues Lima Junior, Russell C Rockne, et al.
Ebiomedicine
|
January 26, 2020
Breast cancer induces systemic immune changes on cytokine signaling in peripheral blood monocytes and lymphocytes
Lei Wang, Diana L Simons, Xuyang Lu, et al.
International Journal of Cancer
|
November 9, 2012
Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients
Neta S Zuckerman, Hongxiang Yu, Diana L Simons, et al.
Nature Immunology
|
July 10, 2019
Connecting blood and intratumoral T<sub>reg</sub> cell activity in predicting future relapse in breast cancer
Lei Wang, Diana L Simons, Xuyang Lu, et al.
NPJ Systems Biology and Applications
|
October 10, 2024
Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients' blood
Brian Orcutt-Jahns, Joao Rodrigues Lima Junior, Emily Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2003
A phase I trial of SD-9427 (progenipoietin) with a multipeptide vaccine for resected metastatic melanoma
Vinod Pullarkat, Peter P Lee, Ronaldo Scotland, et al.
Page
of 13